PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 70,165 | $216,810 | 0.00% |
Legal & General Group Plc | 962 | $2,973 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 331,100 | $1,023,235 | 0.00% |
STATE STREET CORP | 187,209 | $578,476 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 63,867 | $197,349 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 1,066,858 | $3,298 | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 20,149 | $62 | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 37 | $114 | 0.00% |
DEUTSCHE BANK AG\ | 446 | $1,378 | 0.00% |
CITIGROUP INC | 526 | $1,625 | 0.00% |
HSBC HOLDINGS PLC | 23,198 | $70,754 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 123,031 | $380,166 | 0.00% |
GOLDMAN SACHS GROUP INC | 67,688 | $209,156 | 0.00% |
MORGAN STANLEY | 244,470 | $755,411 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 7,023 | $21 | 0.00% |
AMALGAMATED BANK | 964 | $3 | 0.00% |
BlackRock Inc. | 1,068,434 | $3,301,460 | 0.00% |
Bank of New York Mellon Corp | 32,882 | $101,605 | 0.00% |
Citadel Advisors | 200 | $618 | 0.00% |
Citadel Advisors | 1,200 | $3,708 | 0.00% |
External links
This page lists PRELUDE THERAPEUTICS INC's shareholders in Q3 2023. To view PRELUDE THERAPEUTICS INC's shareholder history, click here.